Startseite>>Signaling Pathways>> Membrane Transporter/Ion Channel>> Sodium Channel>>GNE-131

GNE-131

Katalog-Nr.GC31065

GNE-131 ist ein potenter und selektiver Inhibitor des menschlichen Natriumkanals NaV1.7 mit einem IC50 von 3 nM.

Products are for research use only. Not for human use. We do not sell to patients.

GNE-131 Chemische Struktur

Cas No.: 1629063-81-5

Größe Preis Lagerbestand Menge
10mM (in 1mL DMSO)
455,00 $
Auf Lager
5mg
414,00 $
Auf Lager
10mg
597,00 $
Auf Lager
25mg
1.011,00 $
Auf Lager
50mg
1.609,00 $
Auf Lager
100mg
2.712,00 $
Auf Lager

Tel:(909) 407-4943 Email: sales@glpbio.com

Kundenbewertungen

Basiert auf Kundenrezensionen.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

GNE-131 is a potent and selective inhibitor of human sodium channel NaV1.7, with an IC50 of 3 nM.

GNE-131 (Compound 13) shows moderate clearance in human liver microsomes and excellent functional activity against human NaV1.7 with an IC50 of 0.003±0.001 μM. GNE-131 shows excellent potency, good in vitro metabolic stability[1].

GNE-131 shows low in vivo clearance in mouse, rat, and dog. GNE-131 also displays excellent efficacy in a transgenic mouse model of induced pain[1].

[1]. Focken T, et al. Design of Conformationally Constrained Acyl Sulfonamide Isosteres: Identification of N-([1,2,4]Triazolo[4,3- a]pyridin-3-yl)methane-sulfonamides as Potent and Selective hNaV1.7 Inhibitors for the Treatment of Pain. J Med Chem. 2018 Jun 14;61(11):4810-4831.

Bewertungen

Review for GNE-131

Average Rating: 5 ★★★★★ (Based on Reviews and 17 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for GNE-131

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.